Fändrich Fred (1 - 5 of 5 results)

1 patents

Technology Development Manager at GE Idea Works

Bengaluru Area, India | Research

Kremer Bernd Karl Friedrich, Fändrich Fred, Schulze Maren: Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical proparations. Blasticon Biotechnologische Forschung, Kremer Bernd Karl Friedrich, Fändrich Fred, Schulze Maren, VOELKER Ingeborg, January 20, 2005: WO/2005/005620 (3 worldwide citation)

The invention relates to cells of monocytic origin suitable for the prevention and/or treatment of diseases associated with disturbed self-tolerance, in particular autoimmune diseases and allergies, and to pharmaceutical preparations containing these cells. The cells are autologous in relation to th ...

Kremer Bernd Karl Friedrich, Fändrich Fred, Ruhnke Maren: Transplant acceptance inducing cells of monocytic origin and their preparation and use. Blasticon Biotechnologische Forschung, Kremer Bernd Karl Friedrich, Fändrich Fred, Ruhnke Maren, VOELKER Ingeborg, January 22, 2004: WO/2004/007701 (3 worldwide citation)

The invention relates to transplant acceptance inducing cells of monocytic origin, their production as well as their use for generating transplant acceptance. The invention also relates to the monoclonal antibody GM-7, which specifically recognises human transplant acceptance inducing cells of the i ...

Bader Michael, Binas Bert, Chai Giuxuan, Fändrich Fred, Ganten Detlev, Lin Xiongbin: (De) Verwendung von aus embryonalen stammzellen hergeleiteten zellen zur erhöhung der transplantationstoleranz und zur wiederherstellung zerstörten gewebes, (En) Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue. Max Delbrück Centrum Für Molekulare Medizin, Bader Michael, Binas Bert, Chai Giuxuan, Fändrich Fred, Ganten Detlev, Lin Xiongbin, BAUMBACH Fritz, June 13, 2002: WO/2002/046401

(EN) The invention relates to the use of cells from cell lines, which are derived from early embryonic stages, for the donor-specific increase in transplantation tolerance and for repairing damaged tissue. Areas of application of the invention include the field of medicine and the pharmaceutical ind ...

Kremer Bernd Karl Friedrich, Fändrich Fred, Ruhnke Maren: (De) Dedifferenzierte, programmierbare stammzellen monozytären ursprungs, sowie deren herstellung und verwendung, (En) Dedifferentiated, programmable stem cells having a monocytic origin and the production and use thereof. Blasticon Biotechnologische Forschung, Kremer Bernd Karl Friedrich, Fändrich Fred, Ruhnke Maren, VOELKER Ingeborg, October 9, 2003: WO/2003/083091

(EN) The invention relates to the production of adult dedifferentiated, programmable stem cells made of human monocytes by cultivating monocytes in a culture medium containing M-CSF and IL-3. The invention also relates to pharmaceutical preparations containing said dedifferentiated, programmable ste ...

Kremer Bernd Karl Friedrich, Fändrich Fred, Ruhnke Maren: Dedifferentiated, programmable stem cells of monocytic origin, and their production and use. Blasticon Biotechnologische Forschung, Kremer Bernd Karl Friedrich, Fändrich Fred, Ruhnke Maren, VOELKER Ingeborg, October 9, 2003: WO/2003/083092

The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The invention further relates to pharmaceutical preparations, which contain the dedifferentiated, programmabl ...

Click the thumbnails below to visualize the patent trend.